Quality Compounding Rx Of America, Llc

What Quality Compounding Rx Of America, Llc does

Quality Compounding Rx of America, LLC (QCRx) is a 503A compounding pharmacy headquartered in Las Vegas, Nevada, that produces patient-specific compounded medications for individual treatment plans. The company operates a custom-built facility designed to exceed USP <795>, <797>, and <800> standards for non-sterile, sterile, and hazardous drug compounding, with third-party ISO 17025:2017 accredited laboratory testing for sterility and potency verification. Its product portfolio centers on hormone replacement therapy (BHRT), low-dose naltrexone, NAD+ therapy, sexual health compounds, BLT topical anesthetic, GLP-1 receptor agonists (Tirzepatide, Semaglutide), testosterone, ketamine, glutathione, and IV vitamin formulations, delivered in multiple forms including creams, capsules, troches, and injectables.

QCRx generates revenue on a transaction-fee basis through patient-specific compounded prescriptions, with no insurance accepted and pricing handled via quote-based consultation. The go-to-market operates on three complementary motions: a B2B prescriber-relationship model with dedicated account representatives and clinical white papers, an inside sales channel accepting prescriptions via phone, fax, EMR, and the Pharmetika online portal, and a direct-to-consumer motion via website, blog, and social media to drive patient awareness. The company is licensed to ship in 18 US states, with same-day shipping for most products and local delivery in the Las Vegas area. It is privately held with no parent company or institutional investors disclosed, and its leadership team is described as a blend of pharmacists, chemists, engineers, and entrepreneurs.

Name

Quality Compounding Rx Of America, Llc

Legal name

Quality Compounding Rx of America, LLC

Website

https://qcrxusa.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Quality Compounding Rx of America (QCRx) is a 503A compounding pharmacy in Las Vegas, NV producing patient-specific customized medications including hormone therapy, GLP-1s, NAD+, and IV vitamins for healthcare providers and patients across 18 US states.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy Services

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

akta.pro secondary industry

Compounding Pharmacy & Sterile Prep Workflow Systems (HLACAKAM)

Keywords

• Compounding pharmacy services
• Sterile medication compounding
• Bioidentical hormone therapy
• Custom compounded medications
• 503A pharmacy services

Headquarters

HQ city

North Las Vegas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Infrastructure, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Compounded Prescription Medications: One-time prescription-based revenue from patient-specific compounded medications. Prescriptions submitted by licensed healthcare providers for hormone replacement therapy, weight loss, sexual health, dermatology, and other therapeutic areas. Each prescription generates a transaction for customized medications tailored to individual patient needs.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

Quality Compounding Rx of America is a 503A pharmacy that prepares patient-specific sterile and non-sterile compounded medications based on licensed prescriber orders. Its offerings span bioidentical hormone replacement therapy, low dose naltrexone, NAD+ therapy, weight loss compounds, sexual health formulations, IV vitamin drips, dermatology compounds, and topical anesthetics, all prepared in a facility designed to exceed USP <795>, <797>, and <800> standards.

Product overview

Quality Compounding Rx of America is a 503A compounding pharmacy providing custom-compounded medications for individualized patient treatment plans. The core product portfolio centers on Hormone Replacement Therapy (HRT/BHRT), Low Dose Naltrexone (LDN), NAD+ Therapy, Sexual Health & Wellness, and BLT Cream. The company offers an extensive catalog of compounded medications including testosterone preparations, peptide therapies (Tirzepatide, Semaglutide), vitamin injections, dermatology compounds, pain creams, and IV/drip formulations. Products are customized to specific dosing requirements and delivery forms (creams, capsules, injectables, troches) based on prescriber guidance. Additional tools include a dosing calculator for prescribers.

Differentiator

Problem solved

Functional benefit

Products and services

• Hormone Replacement Therapy (BHRT) Custom-formulated bioidentical hormone replacement therapy including estrogen, progesterone, testosterone, and thyroid hormone support in various delivery forms (creams, troches, capsules, injectables) for licensed prescribers and their patients.
• Low Dose Naltrexone (LDN) Custom-compounded Low Dose Naltrexone in capsules at precise strengths (typically 0.5 to 4.5 mg) for immune-regulating and anti-inflammatory benefits in autoimmune disorders, chronic pain, and neurological conditions.
• NAD+ Therapy Compounded NAD+ (Nicotinamide Adenine Dinucleotide) therapy in injectable forms (1000mg/mL) for cellular energy production, DNA repair, addiction therapy, athletic performance, chronic fatigue, cognitive enhancement, and pain management.
• Sexual Health & Wellness Compounding Personalized compounded medications for sexual wellness including erectile dysfunction treatments (TriMix, QuadMix, Sildenafil/Tadalafil combinations), low testosterone therapy, vaginal dryness solutions, and hormonal imbalance support for both men and women.
• BLT Cream Topical anesthetic cream combining Benzocaine, Lidocaine, and Tetracaine for professional pain management in aesthetic and dermatologic procedures including laser therapy, microneedling, and injectables.
• Weight Loss Compounds (GLP-1 Receptor Agonists) Compounded GLP-1 receptor agonist medications including Tirzepatide and Semaglutide for weight management (available in 2.5mg/mL and 1mg/mL concentrations), plus MIC Lipotropic injections for weight management and fat metabolism support.
• IV & Vitamin Drip Compounds IV therapy formulations including vitamin injections (Myers Cocktail with Ascorbic Acid, Magnesium, Calcium, Methylcobalamin, B-Complex), NAD+, glutathione, and other micronutrient drips for wellness and therapeutic applications.
• Dermatology Compounds Custom topical formulations for dermatology including hydroquinone/tretinoin/kojic acid combinations, minoxidil preparations, and various skin treatment compounds for providers and aesthetic practices.

Quantifiable outcome

• Same-day shipping for most products
• +2 more outcomes

Named customers3 records

Segments9 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered minor and core.

• PCCA (Professional Compounding Centers of America)minorOthersPCCA is a complete resource for compounding pharmacies with 4,000 community pharmacists in the United States, Canada, Australia and other countries. Founded in 1981 by a network of pharmacists, PCCA provides support and resources for compounding pharmacy operations.
• LegitScriptcoreOthersLegitScript offers industry-leading certification for the highest levels of commercial integrity in healthcare markets. Their certification is recognized by Google, Microsoft, Facebook, and others for merchants and providers in highly regulated healthcare markets.
• MediscaminorOthersMedisca serves as an important resource for 503A pharmacies, providing technical and clinical expertise, business strategy support, regulatory compliance guidance, and product inventory planning. Often regarded as the safety net in healthcare for patient-tailored care.
• ISO 17025:2017 Accredited LaboratoriescoreTechnology or IntegrationThird-party ISO 17025:2017 accredited labs used for verification of sterility and potency of products, including USP<71> sterility testing and USP<85> endotoxin testing. Provides independent quality verification of compounded products.
• FDA-Registered SupplierscoreTechnology or IntegrationRaw materials sourced from FDA-approved vendors who provide QC testing to ensure high quality standards. All raw materials include incoming verification and testing certification for each new formulation.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Others

• PCCA (Professional Compounding Centers of America): Industry association and supplier providing training, APIs, and formulation support to ~4,000 member compounding pharmacies. QCRx is a PCCA member; PCCA represents the ecosystem of comparable 503A operators and serves as an industry context.
• Medisca: Supplier of APIs, bases, and equipment to compounding pharmacies with technical, clinical, and regulatory support. QCRx is a Medisca partner; comparable as an enabler to the same 503A pharmacy ecosystem.

Direct peers

• Wedgewood Pharmacy: Large compounding pharmacy serving both human and veterinary markets with custom formulations including hormone therapy, dermatology, and wellness compounds. Comparable in patient-specific prescription compounding and prescriber channel.
• AnazaoHealth: 503A compounding pharmacy specializing in sterile and non-sterile preparations including hormone therapy, sexual health compounds, and IV vitamins. Comparable multi-state mail-order compounding model serving prescribers and patients.
• University Compounding Pharmacy: 503A compounding pharmacy specializing in bioidentical hormone replacement therapy and personalized medications. Overlaps with QCRx's BHRT focus and prescriber-driven model.
• Empower Pharmacy: One of the largest 503A/503B compounding pharmacies in the U.S., offering custom sterile and non-sterile compounded medications including HRT, GLP-1s, and wellness compounds. Direct competitor in the patient-specific compounding space with similar therapeutic breadth and prescriber-targeted model.
• Belmar Pharmacy: 503A compounding pharmacy offering customized BHRT, low-dose naltrexone, and other personalized medications with an emphasis on quality and prescriber partnerships. Directly comparable therapeutic portfolio and practitioner-targeted GTM.
• Pentec Health: Sterile compounding pharmacy focused on patient-specific preparations for chronic conditions, parenteral nutrition, and specialty therapies. Comparable in sterile compounding capabilities and prescriber relationship model.
• Triangle Compounding Pharmacy: Compounding pharmacy offering custom sterile and non-sterile preparations including hormone therapy, pain management, and weight loss compounds. Comparable in compounding scope and clinical offerings.

Broad incumbents

• Innovative Pharmacy Services / Clarest Health: Large-scale compounding and specialty pharmacy operator (formerly Pharmedium) serving hospitals and providers with sterile preparations. Broader institutional focus but overlapping sterile compounding capabilities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

• Xx.com/QCRxUSA
• Facebookfacebook.com/QCRxUSA
• LinkedInlinkedin.com/company/quality-compounding-rx-of-america
• Instagraminstagram.com/qcrx_usa
• TikToktiktok.com/@qcrxusa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quality Compounding Rx Of America, Llc